Cargando…
Application of a multiplex urinalysis test for the prediction of intravesical BCG treatment response: A pilot study
BACKGROUND: Intravesical Bacillus Calmette-Guerin (BCG), a live attenuated tuberculosis vaccine that acts as a non-specific immune system stimulant, is the most effective adjuvant treatment for patients with intermediate or high-risk non-muscle-invasive bladder cancer (NMIBC). However, to date, ther...
Autores principales: | Murakami, Kaoru, Kamat, Ashish M., Dai, Yunfeng, Pagano, Ian, Chen, Runpu, Sun, Yijun, Gupta, Amit, Goodison, Steve, Rosser, Charles J., Furuya, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925124/ https://www.ncbi.nlm.nih.gov/pubmed/34511488 http://dx.doi.org/10.3233/CBM-210221 |
Ejemplares similares
-
Influencing Factors on the Oncuria™ Urinalysis Assay: An Experimental Model
por: Murakami, Kaoru, et al.
Publicado: (2021) -
Diagnostic performance of Oncuria™, a urinalysis test for bladder cancer
por: Hirasawa, Yosuke, et al.
Publicado: (2021) -
A Diagnostic Gene Expression Signature for Bladder Cancer Can Stratify Cases into Prescribed Molecular Subtypes and Predict Outcome
por: Chen, Runpu, et al.
Publicado: (2022) -
A multiplex immunoassay for the non-invasive detection of bladder cancer
por: Shimizu, Yoshiko, et al.
Publicado: (2016) -
Clinical Utility of Oncuria™, a Multiplexed Liquid Biopsy for the Non-Invasive Detection of Bladder Cancer—A Pilot Study
por: Murakami, Kaoru, et al.
Publicado: (2022)